| Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell … AM Leen, A Christin, GD Myers, H Liu, CR Cruz, PJ Hanley, ... Blood, The Journal of the American Society of Hematology 114 (19), 4283-4292, 2009 | 368 | 2009 |
| Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral … PJ Hanley, CRY Cruz, B Savoldo, AM Leen, M Stanojevic, M Khalil, ... Blood, The Journal of the American Society of Hematology 114 (9), 1958-1967, 2009 | 289 | 2009 |
| Efficient manufacturing of therapeutic mesenchymal stromal cells with the use of the Quantum Cell Expansion System PJ Hanley, Z Mei, AG Durett, M da Graca Cabreira-Harrison, M Klis, W Li, ... Cytotherapy 16 (8), 1048-1058, 2014 | 154 | 2014 |
| Derivation of human T lymphocytes from cord blood and peripheral blood with antiviral and antileukemic specificity from a single culture as protection against infection and … KP Micklethwaite, B Savoldo, PJ Hanley, AM Leen, GJ Demmler-Harrison, ... Blood, The Journal of the American Society of Hematology 115 (13), 2695-2703, 2010 | 129 | 2010 |
| Adoptive immunotherapy for primary immunodeficiency disorders with virus-specific T lymphocytes S Naik, SK Nicholas, CA Martinez, AM Leen, PJ Hanley, SM Gottschalk, ... Journal of Allergy and Clinical Immunology 137 (5), 1498-1505. e1, 2016 | 122 | 2016 |
| SARS-CoV-2–specific T cells are rapidly expanded for therapeutic use and target conserved regions of the membrane protein MD Keller, KM Harris, MA Jensen-Wachspress, VV Kankate, H Lang, ... Blood, The Journal of the American Society of Hematology 136 (25), 2905-2917, 2020 | 120 | 2020 |
| Controlling cytomegalovirus: helping the immune system take the lead PJ Hanley, CM Bollard Viruses 6 (6), 2242-2258, 2014 | 115 | 2014 |
| CMV-specific T cells generated from naive T cells recognize atypical epitopes and may be protective in vivo PJ Hanley, JJ Melenhorst, S Nikiforow, P Scheinberg, JW Blaney, ... Science translational medicine 7 (285), 285ra63-285ra63, 2015 | 113 | 2015 |
| Adverse events following infusion of T cells for adoptive immunotherapy: a 10-year experience CR Cruz, PJ Hanley, H Liu, V Torrano, YF Lin, JA Arce, S Gottschalk, ... Cytotherapy 12 (6), 743-749, 2010 | 110 | 2010 |
| The time is now: moving toward virus-specific T cells after allogeneic hematopoietic stem cell transplantation as the standard of care F Saglio, PJ Hanley, CM Bollard Cytotherapy 16 (2), 149-159, 2014 | 88 | 2014 |
| Generation of polyclonal CMV-specific T cells for the adoptive immunotherapy of glioblastoma A Ghazi, A Ashoori, PJ Hanley, VS Brawley, DR Shaffer, Y Kew, ... Journal of immunotherapy 35 (2), 159-168, 2012 | 84 | 2012 |
| The effects of age and latent cytomegalovirus infection on the redeployment of CD8+ T cell subsets in response to acute exercise in humans G Spielmann, CM Bollard, AB Bigley, PJ Hanley, JW Blaney, ECP LaVoy, ... Brain, behavior, and immunity 39, 142-151, 2014 | 78 | 2014 |
| Manufacturing mesenchymal stromal cells for phase I clinical trials PJ Hanley, Z Mei, M da Graca Cabreira-Hansen, M Klis, W Li, Y Zhao, ... Cytotherapy 15 (4), 416-422, 2013 | 77 | 2013 |
| Activation of Wnt signaling arrests effector differentiation in human peripheral and cord blood-derived T lymphocytes S Muralidharan, PJ Hanley, E Liu, R Chakraborty, C Bollard, E Shpall, ... The Journal of Immunology 187 (10), 5221-5232, 2011 | 73 | 2011 |
| Immunotherapy of relapsed and refractory solid tumors with ex vivo expanded multi-tumor associated antigen specific cytotoxic T lymphocytes: a phase I study AB Hont, CR Cruz, R Ulrey, B O’Brien, M Stanojevic, A Datar, S Albihani, ... Journal of Clinical Oncology 37 (26), 2349, 2019 | 65 | 2019 |
| EBV/LMP-specific T cells maintain remissions of T-and B-cell EBV lymphomas after allogeneic bone marrow transplantation LP McLaughlin, R Rouce, S Gottschalk, V Torrano, G Carrum, MF Wu, ... Blood, The Journal of the American Society of Hematology 132 (22), 2351-2361, 2018 | 64 | 2018 |
| Mobilizing immune cells with exercise for cancer immunotherapy RJ Simpson, AB Bigley, N Agha, PJ Hanley, CM Bollard Exercise and sport sciences reviews 45 (3), 163-172, 2017 | 64 | 2017 |
| Expansion of T cells targeting multiple antigens of cytomegalovirus, Epstein–Barr virus and adenovirus to provide broad antiviral specificity after stem cell transplantation PJ Hanley, DR Shaffer, CRY Cruz, S Ku, B Tzou, H Liu, ... Cytotherapy 13 (8), 976-986, 2011 | 63 | 2011 |
| Beyond CAR T cells: other cell-based immunotherapeutic strategies against cancer S Patel, RA Burga, AB Powell, EA Chorvinsky, N Hoq, SE McCormack, ... Frontiers in oncology 9, 196, 2019 | 58 | 2019 |
| A single bout of dynamic exercise enhances the expansion of MAGE-A4 and PRAME-specific cytotoxic T-cells from healthy adults. ECP LaVoy, CM Bollard, PJ Hanley, JW Blaney, DP O'Connor, JA Bosch, ... Exercise immunology review 21, 2015 | 58 | 2015 |
Cath BollardProfessor, The George Washington UniversityPotvrđena adresa e-pošte na childrensnational.org
